Skip to main content
Erschienen in: Archives of Gynecology and Obstetrics 4/2011

01.10.2011 | Materno-fetal Medicine

Is colonization with GBS in a previous pregnancy associated with adverse perinatal outcomes?

verfasst von: Adi Y. Weintraub, Roy Kessous, Ruslan Sergienko, Shimrit Salem Yaniv, Fernanda Press, Arnon Wiznitzer, Eyal Sheiner

Erschienen in: Archives of Gynecology and Obstetrics | Ausgabe 4/2011

Einloggen, um Zugang zu erhalten

Abstract

Objective

To investigate whether colonization with GBS in a previous pregnancy is associated subsequently with adverse obstetric and perinatal outcomes.

Methods

A retrospective study was undertaken comparing pregnancy complications of patients with and without colonization with GBS in a previous pregnancy from 1988 to 2006. Women with a positive GBS culture in the current pregnancy, women lacking prenatal care and multiple gestations were excluded from the analysis.

Main outcome measures

Adverse obstetric and perinatal outcomes including premature rupture of membranes, intrapartum fever, chorioamnionitis and perinatal mortality.

Results

Out of 184,266 singleton deliveries, 230 (0.12%) were of patients with a positive GBS culture in their previous pregnancy. Previous GBS colonization was not found to be associated with adverse pregnancy outcomes such as PROM (9.1 vs. 6.8%; P = 0.16), intrapartum fever (1.3 vs. 2.2%; P = 0.72) and chorioamnionitis (1.3 vs. 0.8%; P = 0.29).

Conclusions

GBS colonization in a previous pregnancy is not associated with adverse pregnancy outcomes in the current pregnancy.
Literatur
1.
Zurück zum Zitat Prevention of perinatal group B streptococcal disease: revised guideline from CDC. MMWR Recomm Rep 2002; 51(RR-11):1–22 Prevention of perinatal group B streptococcal disease: revised guideline from CDC. MMWR Recomm Rep 2002; 51(RR-11):1–22
2.
Zurück zum Zitat Baker CJ, Edwards MS (1995) Group B streptococcal infections. In: Remington TA, Klein JO (eds) Infectious diseases of the fetus and newborn, 4th edn. WB Saunders, Philadelphia, pp 980–1054 Baker CJ, Edwards MS (1995) Group B streptococcal infections. In: Remington TA, Klein JO (eds) Infectious diseases of the fetus and newborn, 4th edn. WB Saunders, Philadelphia, pp 980–1054
3.
Zurück zum Zitat Eidelman AI, Rudensky B, Turgeman D, Nubani N, Schimmel MS, Isachson M (1990) Epidemiology of perinatal group B streptococci colonization and disease in mothers and infants. Update of ongoing 10 years Jerusalem study. Isr J Med Sci 26:71–73PubMed Eidelman AI, Rudensky B, Turgeman D, Nubani N, Schimmel MS, Isachson M (1990) Epidemiology of perinatal group B streptococci colonization and disease in mothers and infants. Update of ongoing 10 years Jerusalem study. Isr J Med Sci 26:71–73PubMed
4.
Zurück zum Zitat Schimmel MS, Eidelman AI, Rudensky B (1994) Epidemiology of group B streptococcal colonization and infection in Jerusalem 1989–1991. Isr J Med Sci 30:349–351PubMed Schimmel MS, Eidelman AI, Rudensky B (1994) Epidemiology of group B streptococcal colonization and infection in Jerusalem 1989–1991. Isr J Med Sci 30:349–351PubMed
5.
Zurück zum Zitat Schimmel MS, Samueloff A, Eidelman AI (1998) Prevention of neonatal group B streptococcal infections. Is there a rational prevention strategy? Clin Perinatol 25:687–697PubMed Schimmel MS, Samueloff A, Eidelman AI (1998) Prevention of neonatal group B streptococcal infections. Is there a rational prevention strategy? Clin Perinatol 25:687–697PubMed
6.
Zurück zum Zitat Eisenberg VH, Raveh D, Meislish Y, Rudensky B, Ezra Y, Samueloff A, Eidelman AI, Schimmel MS (2006) Prevention of early-onset neonatal group B streptococcal infection: is universal screening by culture universally applicable? Isr Med Assoc J 8(10):698–702PubMed Eisenberg VH, Raveh D, Meislish Y, Rudensky B, Ezra Y, Samueloff A, Eidelman AI, Schimmel MS (2006) Prevention of early-onset neonatal group B streptococcal infection: is universal screening by culture universally applicable? Isr Med Assoc J 8(10):698–702PubMed
7.
Zurück zum Zitat Marchaim D, Gortzak-Uzan L, Peled N, Riesenberg K, Schlaeffer F (2003) Cell wall proteins of group B streptococcus, low incidence of neonatal disease in southern Israel. J Reprod Med 48(9):697–702PubMed Marchaim D, Gortzak-Uzan L, Peled N, Riesenberg K, Schlaeffer F (2003) Cell wall proteins of group B streptococcus, low incidence of neonatal disease in southern Israel. J Reprod Med 48(9):697–702PubMed
8.
Zurück zum Zitat Garland SM (1991) Early-onset neonatal group B streptococcus (GBS) infection: associated obstetric factors. Aust NZJ Obstet Gynaecol 31:117–118CrossRef Garland SM (1991) Early-onset neonatal group B streptococcus (GBS) infection: associated obstetric factors. Aust NZJ Obstet Gynaecol 31:117–118CrossRef
9.
Zurück zum Zitat Regan JA, Klebanoff MA, Nugent RP (1996) Colonization with group B Streptococci in pregnancy and adverse outcome. VIP Study Group. Am J Obstet Gynaecol 174:1354–1360CrossRef Regan JA, Klebanoff MA, Nugent RP (1996) Colonization with group B Streptococci in pregnancy and adverse outcome. VIP Study Group. Am J Obstet Gynaecol 174:1354–1360CrossRef
10.
Zurück zum Zitat Moller M, Thomsen AC, Borch K (1984) Rupture of fetal membranes and premature delivery associated with group B streptococci in urine of pregnant women. Lancet 2:69–70PubMedCrossRef Moller M, Thomsen AC, Borch K (1984) Rupture of fetal membranes and premature delivery associated with group B streptococci in urine of pregnant women. Lancet 2:69–70PubMedCrossRef
11.
Zurück zum Zitat McDonald HM, O’Loughlin JA, Jolley P, Vigneswaran R, McDonald PJ (1991) Vaginal infection and preterm labor. Brit J Obstet Gynaecol 98:427–435CrossRef McDonald HM, O’Loughlin JA, Jolley P, Vigneswaran R, McDonald PJ (1991) Vaginal infection and preterm labor. Brit J Obstet Gynaecol 98:427–435CrossRef
12.
Zurück zum Zitat Schuchat A, Oxtoby M, Cochi S (1990) Population-based risk factors for neonatal group B streptococcal disease: results of a cohort study in metropolitan Atlanta. J Infect Dis 162:672–677PubMedCrossRef Schuchat A, Oxtoby M, Cochi S (1990) Population-based risk factors for neonatal group B streptococcal disease: results of a cohort study in metropolitan Atlanta. J Infect Dis 162:672–677PubMedCrossRef
13.
Zurück zum Zitat Gibbs RS, Schrag S, Schuchat A (2004) Perinatal infections due to group B streptococci. Obstet Gynecol 104:1062–1076PubMedCrossRef Gibbs RS, Schrag S, Schuchat A (2004) Perinatal infections due to group B streptococci. Obstet Gynecol 104:1062–1076PubMedCrossRef
14.
Zurück zum Zitat Rouse DJ, Goldenberg RL, Cliver SP, Cutter GR, Mennemeyer ST, Fargason CA Jr (1994) Strategies for the prevention of early-onset neonatal group B streptococcal sepsis: a decision analysis. Obstet Gynecol 83:483–494PubMedCrossRef Rouse DJ, Goldenberg RL, Cliver SP, Cutter GR, Mennemeyer ST, Fargason CA Jr (1994) Strategies for the prevention of early-onset neonatal group B streptococcal sepsis: a decision analysis. Obstet Gynecol 83:483–494PubMedCrossRef
15.
Zurück zum Zitat Faxelius G, Bremme K, Christensen KK, Christensen P, Ringertz S (1988) Neonatal septicemia due to group B streptococci—perinatal risk factors and outcome of subsequent pregnancies. J Perinat Med 16:423–430PubMedCrossRef Faxelius G, Bremme K, Christensen KK, Christensen P, Ringertz S (1988) Neonatal septicemia due to group B streptococci—perinatal risk factors and outcome of subsequent pregnancies. J Perinat Med 16:423–430PubMedCrossRef
16.
Zurück zum Zitat Christensen KK, Dahlander K, Linden V, Svenningsen N, Christensen P (1981) Obstetrical care in future pregnancies after fetal loss in group B streptococcal septicemia. A prevention program based on bacteriological and immunological follow-up. Eur J Obstet Gynecol Reprod Biol 12:143–150PubMedCrossRef Christensen KK, Dahlander K, Linden V, Svenningsen N, Christensen P (1981) Obstetrical care in future pregnancies after fetal loss in group B streptococcal septicemia. A prevention program based on bacteriological and immunological follow-up. Eur J Obstet Gynecol Reprod Biol 12:143–150PubMedCrossRef
17.
Zurück zum Zitat Twizer I, Sheiner E, Hallak M, Mazor M, Katz M, Shoham-Vardi I (2001) Lack of prenatal care in a traditional society. Is it an obstetric hazard? J Reprod Med 46:662–668PubMed Twizer I, Sheiner E, Hallak M, Mazor M, Katz M, Shoham-Vardi I (2001) Lack of prenatal care in a traditional society. Is it an obstetric hazard? J Reprod Med 46:662–668PubMed
18.
Zurück zum Zitat Sheiner E, Shoham-Vardi I, Weitzman D, Gohar J, Carmi R (1998) Decisions regarding pregnancy termination among Bedouin couples referred to third level ultrasound clinic. Eur J Obstet Gynecol Reprod Biol 76:141–146PubMedCrossRef Sheiner E, Shoham-Vardi I, Weitzman D, Gohar J, Carmi R (1998) Decisions regarding pregnancy termination among Bedouin couples referred to third level ultrasound clinic. Eur J Obstet Gynecol Reprod Biol 76:141–146PubMedCrossRef
Metadaten
Titel
Is colonization with GBS in a previous pregnancy associated with adverse perinatal outcomes?
verfasst von
Adi Y. Weintraub
Roy Kessous
Ruslan Sergienko
Shimrit Salem Yaniv
Fernanda Press
Arnon Wiznitzer
Eyal Sheiner
Publikationsdatum
01.10.2011
Verlag
Springer-Verlag
Erschienen in
Archives of Gynecology and Obstetrics / Ausgabe 4/2011
Print ISSN: 0932-0067
Elektronische ISSN: 1432-0711
DOI
https://doi.org/10.1007/s00404-010-1724-6

Weitere Artikel der Ausgabe 4/2011

Archives of Gynecology and Obstetrics 4/2011 Zur Ausgabe

Hirsutismus bei PCOS: Laser- und Lichttherapien helfen

26.04.2024 Hirsutismus Nachrichten

Laser- und Lichtbehandlungen können bei Frauen mit polyzystischem Ovarialsyndrom (PCOS) den übermäßigen Haarwuchs verringern und das Wohlbefinden verbessern – bei alleiniger Anwendung oder in Kombination mit Medikamenten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Weniger postpartale Depressionen nach Esketamin-Einmalgabe

Bislang gibt es kein Medikament zur Prävention von Wochenbettdepressionen. Das Injektionsanästhetikum Esketamin könnte womöglich diese Lücke füllen.

Bei RSV-Impfung vor 60. Lebensjahr über Off-Label-Gebrauch aufklären!

22.04.2024 DGIM 2024 Kongressbericht

Durch die Häufung nach der COVID-19-Pandemie sind Infektionen mit dem Respiratorischen Synzytial-Virus (RSV) in den Fokus gerückt. Fachgesellschaften empfehlen eine Impfung inzwischen nicht nur für Säuglinge und Kleinkinder.

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.